Arterys
Arterys is a cloud-based medical imaging AI platform that delivers visualization, quantification, and triage tools for radiology departments in hospitals and health systems. Founded in 2013, acquired by Tempus AI in 2022, and now operating as Tempus Radiology, it focuses primarily on cardiology and oncology imaging workflows.
- Company typePrivate
- Founded2014
- HeadquartersSan Francisco, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Arterys does
Arterys is a cloud-based medical imaging AI platform that delivers visualization, quantification, and triage tools for radiology departments, with particular focus on cardiology and oncology imaging studies. Founded in 2013 and headquartered in San Francisco, the platform operates as a validated medical device accessible from any validated device via the cloud, with no PHI exchange required, and integrates directly into existing PACS or EHR-driven clinical workflows so that AI capabilities are a natural extension of how radiologists already work. Underlying the platform are deep learning computer vision models applied across modalities including CT, MRI, and mammography, used to flag urgent findings, manage rising imaging volumes, and improve diagnostic accuracy amid radiologist shortages.
The product processes DICOM and other medical imaging formats and combines image analysis with multimodal clinical data integration, enabling actionable diagnostic insights rather than isolated stand-alone reads. Prior to its acquisition by Tempus AI in 2022, Arterys had raised approximately $71.7 million across eight funding events with strategic participation from Temasek, GE Ventures, Varian, Northwell Ventures, NewYork-Presbyterian Ventures, and Fosun Capital, validating institutional and ecosystem confidence in the platform. Following the acquisition, the product has been reintroduced as Tempus Radiology and is being integrated into Tempus's broader precision medicine stack, extending the offering from clinical diagnostic use into life sciences research and drug development by leveraging radiology as a new data modality alongside Tempus's molecular and clinical assets.
Arterys generates revenue through an enterprise SaaS subscription model, with quote-based (non-public) pricing sold via direct enterprise sales to hospitals, health systems, and radiology departments. The go-to-market motion is field-led and integration-heavy: deals involve technical integration with PACS/EHR systems, validation against clinical workflows, and ongoing customer success. Distribution is now channeled through Tempus's existing healthcare provider and pharmaceutical relationships, materially broadening reach relative to Arterys's pre-acquisition direct footprint. Direct marketing emphasizes clinical publications, industry conference presence, FDA-related regulatory positioning, and PACS/EHR integration partnerships rather than consumer or SMB channels, consistent with the enterprise radiology AI category.
Arterys firmographics
Firmographics- Name
- Arterys
- Legal name
- Arterys
- Website
- https://arterys.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Acquired
- Headcount range
- 51–100 employees
- Short description
- Arterys is a cloud-based medical imaging AI platform that delivers visualization, quantification, and triage tools for radiology departments in hospitals and health systems. Founded in 2013, acquired by Tempus AI in 2022, and now operating as Tempus Radiology, it focuses primarily on cardiology and oncology imaging workflows.
- Ownership category
- akta.pro rank
Arterys industry classification
Industry- Product category
- Medical Imaging AI / Radiology AI Software
- NAICS
- Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Computer Systems Design and Related Services (54151)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Medical Imaging AI (HDAAAEAH)
- akta.pro secondary industries
- AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD), Imaging Informatics & Workflow (PACS/RIS/VNA) (HLAHABAI)
Keywords
Where Arterys is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Markets served
Arterys business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Medical Imaging AI SaaS Platform: Arterys generates revenue through a cloud-based SaaS subscription model for its medical imaging AI platform. Healthcare institutions pay for access to AI-powered diagnostic tools that integrate directly into their clinical workflows. The platform extracts actionable insights from medical images to improve diagnostic decision-making, efficiency, and productivity, serving as a validated medical device in radiology departments.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Arterys product offering
Product offeringCore offering
Arterys provides a cloud-based medical imaging AI platform that extracts actionable insights from radiology images (CT, MRI, mammography) to improve diagnostic decision-making, efficiency, and productivity. The platform weaves leading AI clinical applications directly into existing PACS or EHR-driven workflows across cardiology and oncology use cases, operating as a validated medical device with no PHI exchange required. Following its 2022 acquisition by Tempus AI, the product is being integrated into Tempus' broader precision medicine platform and reintroduced as Tempus Radiology.
Product overview
Arterys is a cloud-based medical imaging AI platform that functions as the radiology AI component within the broader Tempus precision medicine ecosystem. Following Tempus's 2022 acquisition of Arterys, the platform has been rebranded as Tempus Radiology, integrating AI-powered image analysis into Tempus's existing data and AI infrastructure. The platform operates exclusively via the cloud, requiring no PHI exchange, and provides visualization, quantification, and triage capabilities across multiple radiology modalities (CT, MRI, mammography, and others) for cardiology and oncology use cases. The Arterys product serves as the core medical imaging AI engine that enables providers to access a comprehensive patient view inclusive of radiology scans, and researchers to leverage this new imaging data modality to optimize drug development.
Differentiator
Problem solved
Functional benefit
Products and services
- Arterys Medical Imaging AI Platform A cloud-based medical imaging AI platform that extracts actionable insights from radiology images to improve diagnostic decision-making, efficiency, and patient outcomes by weaving AI clinical applications into existing PACS or EHR-driven workflows for hospitals, health systems, and radiology departments across cardiology and oncology use cases.
Quantifiable outcome
- Arterys is referenced as a leading AI radiology tool alongside Aidoc and Gleamer for triage and flagging functionality
Companies that use Arterys
Customer profileSegments2 records
Ideal customer profiles2 records
Arterys technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature3 records
Arterys partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
Arterys competitors and assessment
Company assessmentDirect peers
- RapidAI: RapidAI delivers AI imaging solutions for stroke, aneurysm, and other vascular conditions, integrated into hospital PACS workflows. It is directly comparable to Arterys in product category, hospital-system sales motion, and AI-augmented radiology decision-making.
- Viz.ai: Viz.ai provides AI-powered medical imaging analysis focused on stroke and acute care triage, integrated with hospital workflows. It is directly comparable to Arterys in target customers (hospital systems), enterprise SaaS model, and AI-driven radiology decision support.
- Qure.ai: Qure.ai builds deep learning models for medical imaging interpretation across chest, head, and musculoskeletal use cases, deployed in hospitals globally. It is directly comparable to Arterys in AI radiology technology and enterprise hospital sales approach.
- Nanox (formerly Zebra Medical Vision): Zebra Medical Vision, now part of Nanox, developed AI algorithms for radiology image analysis deployed across multiple modalities. It is directly comparable to Arterys as an AI medical imaging platform serving hospital radiology departments.
- Aidoc: Aidoc is a leading medical imaging AI platform focused on radiology triage and detection, deployed across hospital systems. It is directly comparable to Arterys as both target hospital radiology workflows with AI-driven image analysis, and is cited alongside Arterys and Gleamer in industry comparisons.
- Gleamer: Gleamer develops AI radiology software for triage and detection, with strong positioning in musculoskeletal and chest imaging. It is directly comparable to Arterys, referenced alongside it as a peer in the AI radiology market and competing for similar hospital contracts.
Broad incumbents
- Tempus AI: Tempus AI is the parent company of Arterys (now Tempus Radiology), operating a broader precision medicine platform spanning genomics, clinical data, and now imaging. It is a broad incumbent whose strategy now sets Arterys's trajectory and provides distribution scale.
- Philips (IntelliSpace AI): Philips offers a broad imaging and informatics portfolio including IntelliSpace AI, an enterprise imaging AI platform. It is a broad incumbent comparable to Arterys in hospital imaging AI and enterprise radiology workflow integration.
- GE HealthCare: GE HealthCare is a major imaging equipment and informatics vendor with AI capabilities embedded across its imaging portfolio. It is a broad incumbent overlapping with Arterys in hospital radiology AI and imaging informatics, and was also an Arterys investor via GE Ventures.
Emerging players
- Annalise.ai: Annalise.ai offers comprehensive AI radiology decision-support across a broad range of imaging findings. It is an emerging peer with meaningful overlap to Arterys in AI-powered radiology interpretation for hospital customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Arterys social profiles
Digital presenceArterys financial estimates
Financial estimateRevenue estimate
Valuation estimate
Arterys leadership team
Management profileNumber of profiles
Profiles5 records
Arterys funding detail
Funding detailFunding overview
Funding rounds8 records
Investors17 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Arterys M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Arterys
What does Arterys do?
Arterys provides a cloud-based medical imaging AI platform that extracts actionable insights from radiology images (CT, MRI, mammography) to improve diagnostic decision-making, efficiency, and productivity. The platform weaves leading AI clinical applications directly into existing PACS or EHR-driven workflows across cardiology and oncology use cases, operating as a validated medical device with no PHI exchange required. Following its 2022 acquisition by Tempus AI, the product is being integrated into Tempus' broader precision medicine platform and reintroduced as Tempus Radiology.
Is Arterys a public or private company?
Arterys is a private company. It is classified as corporate owned and is currently acquired.
When was Arterys founded?
Arterys was founded in 2014. It employs 51 to 100 people.
Where is Arterys based?
Arterys is headquartered in San Francisco, United States, in the North America region.
How does Arterys make money?
One revenue line is on record: medical Imaging AI SaaS Platform.
Who are Arterys's main competitors?
Direct peers on record are RapidAI, Viz.ai, Qure.ai, Nanox (formerly Zebra Medical Vision), Aidoc and Gleamer. Broad incumbents are Tempus AI, Philips (IntelliSpace AI) and GE HealthCare. Annalise.ai is listed as an emerging player.
Does Arterys have an API?
No public API is recorded for Arterys.
What industry is Arterys in?
Arterys's product category is Medical Imaging AI / Radiology AI Software. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 33451 and its SIC code is 3841.